ログイン 会員登録
icon_bulk_order一括注文 Acrobiosystems for English
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
phone
Your Position: ホーム > Catenin beta-1

Catenin beta-1

概要

Name:Catenin beta 1
Target Synonym:NEDSDV,OK/SW-cl.35,CTNNB1,PRO2286,Catenin Beta 1,Catenin (Cadherin-Associated Protein), Beta 1, 88kDa,CTNNB,Catenin (Cadherin-Associated Protein), Beta 1 (88kD),Catenin (Cadherin-Associated Protein), Beta 1,Catenin Beta-1,Beta-Catenin,Armadillo,MRD19,EVR7,beta Catenin,β-Catenin
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:8
Lastest Research Phase:Phase 2 Clinical

製品リスト製品比較と製品注文

製品仕様別:
製品カテゴリー別:
種類別:
コンジュゲート:
製造番号 種類 製品説明 構造 純度 特徴
CA1-H81E3 Human Biotinylated Human Catenin beta-1 Protein, His,Avitag™ (MALS verified)
CA1-H81E3-structure
CA1-H81E3-sds
CA1-H51H3 Human Human Catenin beta-1 Protein, His Tag (MALS verified)
CA1-H51H3-structure
CA1-H51H3-sds
ACRO Quality

生物活性データの一部

CA1-H81E3-MALS-HPLC
Catenin beta-1 MALS images

The purity of Biotinylated Human Catenin beta-1, His,Avitag (Cat. No. CA1-H81E3) is more than 95% and the molecular weight of this protein is around 62-72 kDa verified by SEC-MALS.

CA1-H51H3-MALS-HPLC
Catenin beta-1 MALS images

The purity of Human Catenin beta-1 Protein, His Tag (Cat. No. CA1-H51H3) is more than 90% and the molecular weight of this protein is around 55-70 kDa verified by SEC-MALS.

臨床試験情報

Name Research Code Research Phase Company Indications Clinical Trials
CEQ-508 CEQ-508 Phase 2 Clinical Marina Biotech Adenomatous Polyposis Coli Details
Foscenvivint PRI-724; ICG-001; OP-724 Phase 2 Clinical University Of Southern California, Prism Pharma Co Ltd Leukemia, Myelogenous, Chronic; Liver Cirrhosis, Biliary; Solid tumours; Pancreatic Neoplasms; Liver Cirrhosis; Hepatitis B; Hepatitis C; Colorectal Neoplasms; Leukemia, Myeloid, Acute Details
Tegatrabetan BC-2059; APL-121 Phase 2 Clinical Allergan Plc Sarcoma, Ewing; Fibroma; Melanoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Endometrial Neoplasms; Lymphoma, Non-Hodgkin; Lung Neoplasms; Colorectal Neoplasms; Neuroblastoma; Solid tumours; Osteosarcoma; Lymphoma, Large B-Cell, Diffuse; Neoplasms; Pancreatic Neoplasms; Carcinoma, Ovarian Epithelial; Wilms Tumor; Hepatoblastoma; Lymphoma, B-Cell; Fibromatosis, Aggressive; Leukemia Details
CWP-232291 CWP-291; CWP-232291 Phase 2 Clinical Jw Pharmaceutical Corp Leukemia, Myelomonocytic, Chronic; Myelodysplastic Syndromes; Multiple Myeloma; Primary Myelofibrosis; Leukemia, Myeloid, Acute Details
FOG-001 FOG-001 Phase 2 Clinical Fog Pharmaceuticals Inc Adenomatous Polyposis Coli; Solid tumours; Esophageal Neoplasms; Stomach Neoplasms; Neoplasms; Digestive System Neoplasms; Colorectal Neoplasms; Gastrointestinal Neoplasms; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis Details
E-7386 E-7386 Phase 2 Clinical Prism Pharma Co Ltd, Eisai Co Ltd Liver Neoplasms; Solid tumours; Neoplasms; Colorectal Neoplasms; Endometrial Neoplasms; Melanoma; Carcinoma, Hepatocellular; Gastrointestinal Neoplasms Details
ALN-BCAT ALN-BCAT Phase 1 Clinical Alnylam Pharmaceuticals Inc Carcinoma, Hepatocellular Details
ST-316 ST-316 Phase 1 Clinical Sapience Therapeutics Inc Hematologic Neoplasms; Solid tumours; Ovarian Neoplasms; Colonic Neoplasms; Pancreatic Neoplasms; Skin Neoplasms; Triple Negative Breast Neoplasms; Sarcoma, Synovial; Cholangiocarcinoma; Metastatic breast cancer; Carcinoma, Non-Small-Cell Lung; Melanoma; Carcinoma, Hepatocellular Details
VTX-003 Neoplasms Details
CEQ-508 CEQ-508 Phase 2 Clinical Marina Biotech Adenomatous Polyposis Coli Details
Foscenvivint PRI-724; ICG-001; OP-724 Phase 2 Clinical University Of Southern California, Prism Pharma Co Ltd Leukemia, Myelogenous, Chronic; Liver Cirrhosis, Biliary; Solid tumours; Pancreatic Neoplasms; Liver Cirrhosis; Hepatitis B; Hepatitis C; Colorectal Neoplasms; Leukemia, Myeloid, Acute Details
Tegatrabetan BC-2059; APL-121 Phase 2 Clinical Allergan Plc Sarcoma, Ewing; Fibroma; Melanoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Endometrial Neoplasms; Lymphoma, Non-Hodgkin; Lung Neoplasms; Colorectal Neoplasms; Neuroblastoma; Solid tumours; Osteosarcoma; Lymphoma, Large B-Cell, Diffuse; Neoplasms; Pancreatic Neoplasms; Carcinoma, Ovarian Epithelial; Wilms Tumor; Hepatoblastoma; Lymphoma, B-Cell; Fibromatosis, Aggressive; Leukemia Details
CWP-232291 CWP-291; CWP-232291 Phase 2 Clinical Jw Pharmaceutical Corp Leukemia, Myelomonocytic, Chronic; Myelodysplastic Syndromes; Multiple Myeloma; Primary Myelofibrosis; Leukemia, Myeloid, Acute Details
FOG-001 FOG-001 Phase 2 Clinical Fog Pharmaceuticals Inc Adenomatous Polyposis Coli; Solid tumours; Esophageal Neoplasms; Stomach Neoplasms; Neoplasms; Digestive System Neoplasms; Colorectal Neoplasms; Gastrointestinal Neoplasms; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis Details
E-7386 E-7386 Phase 2 Clinical Prism Pharma Co Ltd, Eisai Co Ltd Liver Neoplasms; Solid tumours; Neoplasms; Colorectal Neoplasms; Endometrial Neoplasms; Melanoma; Carcinoma, Hepatocellular; Gastrointestinal Neoplasms Details
ALN-BCAT ALN-BCAT Phase 1 Clinical Alnylam Pharmaceuticals Inc Carcinoma, Hepatocellular Details
ST-316 ST-316 Phase 1 Clinical Sapience Therapeutics Inc Hematologic Neoplasms; Solid tumours; Ovarian Neoplasms; Colonic Neoplasms; Pancreatic Neoplasms; Skin Neoplasms; Triple Negative Breast Neoplasms; Sarcoma, Synovial; Cholangiocarcinoma; Metastatic breast cancer; Carcinoma, Non-Small-Cell Lung; Melanoma; Carcinoma, Hepatocellular Details
VTX-003 Neoplasms Details

This web search service is supported by Google Inc.

totopphone